Continuous Inhibition of Epidermal Growth Factor Receptor Phosphorylation by Erlotinib Enhances Antitumor Activity of Chemotherapy in Erlotinib-Resistant Tumor Xenografts
Oncology Reports - Greece
doi 10.3892/or.2011.1614
Full Text
Open PDFAbstract
Available in full text
Date
December 30, 2011
Authors
Publisher
Spandidos Publications